Fermann Publishes Cochrane Review on Nitrates
Gregory Fermann, MD, associate professor and executive vice chairman of emergency medicine, was just published in a Cochrane Review of "Nitrates for acute heart failure syndromes.
Cochrane Reviews, systematic reviews of primary research in human health care and health policy, are often viewed as the pinnacle of evidence-based knowledge on a topic.
In their review, Fermann and co-authors studied the clinical efficacy and safety of nitrate vasodilators in acute heart failure syndrome (AHFS).
In reviewing four studies of 634 patients with AHFS employing two types of nitrates (isosorbide dinitrate and nitroglycerin), the research team concluded there is no significant difference between nitrates and alternative treatment interventions for patients with AHFS in terms of healthcare outcomes. Nitrates appeared to be well tolerated in all four studies.
Read the full review online.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.